New Capital Fund Plc - New Capital Healthcare Disruptors Fund P Fonds
97,31
USD
+0,11
USD
+0,11
%
NAV
Werbung
Anlageziel
The investment objective of the Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade across all market capitalizations. The Sub-Fund may invest up to a maximum of 20% of the Net Asset Value in non-US companies including up to 10% of its assets in securities of emerging market issuers.
Stammdaten
Name | New Capital UCITS Fund Plc - New Capital Healthcare Disruptors Fund USD P Acc Fonds |
ISIN | IE00BN6JWN83 |
WKN | A3CPDJ |
Fondsgesellschaft | EFG Asset Management (UK) Ltd |
Benchmark | MSCI World/Health Care |
Ausschüttungsart | Thesaurierend |
Manager | Michael D. Clulow |
Domizil | Ireland |
Fondskategorie | Aktien |
Auflagedatum | 17.05.2021 |
Geschäftsjahr | 30.06. |
VL-fähig? | Nein |
Depotbank | HSBC Continental Europe |
Zahlstelle | EFG Bank AG |
Riester Fonds | Nein |
Basisdaten
Auflagedatum | 17.05.2021 |
Depotbank | HSBC Continental Europe |
Zahlstelle | EFG Bank AG |
Domizil | Ireland |
Geschäftsjahr | 30.06. |
Aktuelle Daten
Morningstar Rating | |
Aktueller Rücknahmepreis | 97,31 |
Anzahl Fonds der Kategorie | 788 |
Volumen der Tranche | 20,40 Mio. USD |
Fondsvolumen | 81,90 Mio. USD |
Total Expense Ratio (TER) | 1,00 |
Gebühren
Laufende Kosten | 1,20% |
Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 1,00% |
Transaktionskosten | 0,20% |
Depotbankgebühr | - |
Managementgebühr | 0,80% |
Rücknahmegebühr | - |
Ausgabeaufschlag | - |
Performancedaten
Veränderung Vortag | 0,11 |
WE seit Jahresbeginn | 7,05% |